MAAT INDEX

CLAIM #58535 · UnitedHealth Group Incorporated (UNH) · 2022Q2 earnings call · Jul 15, 2022 · due Dec 31, 2022

So we're tracking nicely towards our growth agenda of adding 10,000 physicians and advanced practitioners during the year, and look forward to following up with you at the investor conference to share those numbers.

Wyatt Decker · Executive

PENDING
graded after results covering Dec 31, 2022 are reported

In context

in. I'm going to ask John in a second to talk to the margin progression opportunity. But maybe first, Dr. Decker, Head of Optum Health, might speak to the whole dynamic around physician recruitment? Wyatt Decker: Yes. Kevin, thanks for the question. Absolutely, we are seeing continued growth of our physicians in Optum Health and Optum Care. What we’ve found is that physicians are increasingly attracted to the value proposition that we offer them, which is less clerical burden and more focused on doing the work that they love, which is providing clinical care. Moving physicians to value-based care paradigms is especially appealing. So you're seeing us appeal to large groups like Atrius and Kelsey that have recently joined Optum Health, as well as doctors coming straight out of residency. So we're tracking nicely towards our growth agenda of adding 10,000 physicians and advanced practitioners during the year, and look forward to following up with you at the investor conference to share those numbers. John Rex : Good morning, Kevin, it's John here. So considering the growth in Optum Health and the earnings progression that you should expect out of that, the primary focus continues to be on expanding our capabilities for value-based care, that build out. These investments, as you know well because you've looked at this for a while, are made well in advance of any revenue impact that we get from bringing those physicians on. As we look at our pipeline, so when I talk pipeline, there are 2 ways to think about it. It's both potential future ads. But when I'm talking about it now with you here, I'm talking about even our existing base of clinical care delivery capabilities and where we have to build out that capability in terms of future value-based expansion. We're still quite early stage

Verify independently

SEC filings for UNH · Claim quote is verbatim from the 2022Q2 earnings call.